关注
Efisio Puxeddu
Efisio Puxeddu
Associate Professor, University of Perugia
在 unipg.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer
M Xing, AS Alzahrani, KA Carson, D Viola, R Elisei, B Bendlova, L Yip, ...
Jama 309 (14), 1493-1501, 2013
10452013
Association between BRAF V600E mutation and recurrence of papillary thyroid cancer
M Xing, AS Alzahrani, KA Carson, YK Shong, TY Kim, D Viola, R Elisei, ...
Journal of clinical oncology 33 (1), 42, 2015
6032015
Androgen receptor mutations in prostate cancer
M Marcelli, M Ittmann, S Mariani, R Sutherland, R Nigam, L Murthy, ...
Cancer research 60 (4), 944-949, 2000
5142000
The natural history of benign thyroid nodules
C Durante, G Costante, G Lucisano, R Bruno, D Meringolo, A Paciaroni, ...
Jama 313 (9), 926-935, 2015
4992015
BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism
C Durante, E Puxeddu, E Ferretti, R Morisi, S Moretti, R Bruno, F Barbi, ...
The Journal of Clinical Endocrinology & Metabolism 92 (7), 2840-2843, 2007
4602007
BRAFV599E Mutation Is the Leading Genetic Event in Adult Sporadic Papillary Thyroid Carcinomas
E Puxeddu, S Moretti, R Elisei, C Romei, R Pascucci, M Martinelli, ...
The Journal of Clinical Endocrinology & Metabolism 89 (5), 2414-2420, 2004
3512004
Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: Molecular diversity and associated phenotypic spectrum
A Sarkozy, C Carta, S Moretti, G Zampino, MC Digilio, F Pantaleoni, ...
Human mutation 30 (4), 695-702, 2009
3452009
Correlation between B-RAFV600E mutation and clinico–pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature
L Fugazzola, E Puxeddu, N Avenia, C Romei, V Cirello, A Cavaliere, ...
Endocrine-related cancer 13 (2), 455-464, 2006
2882006
Differential clinicopathological risk and prognosis of major papillary thyroid cancer variants
X Shi, R Liu, F Basolo, R Giannini, X Shen, D Teng, H Guan, Z Shan, ...
The Journal of Clinical Endocrinology 101 (1), 264-274, 2016
2362016
B-RafV600E and thrombospondin-1 promote thyroid cancer progression
C Nucera, A Porrello, ZA Antonello, M Mekel, MA Nehs, TJ Giordano, ...
Proceedings of the National Academy of Sciences 107 (23), 10649-10654, 2010
2032010
Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR®: biodistribution, pharmacokinetic features and in vivo antitumor activity
D Paolino, D Cosco, L Racanicchi, E Trapasso, C Celia, M Iannone, ...
Journal of Controlled Release 144 (2), 144-150, 2010
1462010
of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO# 2)
L Lamartina, G Grani, E Arvat, A Nervo, MC Zatelli, R Rossi, E Puxeddu, ...
Endocrine-Related Cancer 25 (3), L7-L11, 2018
1412018
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes
C Romei, S Mariotti, L Fugazzola, A Taccaliti, F Pacini, G Opocher, C Mian, ...
European Journal of Endocrinology 163 (2), 301-308, 2010
1332010
Modifications in the papillary thyroid cancer gene profile over the last 15 years
C Romei, L Fugazzola, E Puxeddu, F Frasca, D Viola, M Muzza, S Moretti, ...
The Journal of Clinical Endocrinology & Metabolism 97 (9), E1758-E1765, 2012
1252012
Surgical treatment of intrathyroid metastases: preliminary results of a multicentric study
F Calzolari, PV Sartori, C Talarico, D Parmeggiani, E Beretta, L Pezzullo, ...
Anticancer research 28 (5B), 2885-2888, 2008
1252008
Epigenetics of thyroid cancer and novel therapeutic targets.
D Russo, G Damante, E Puxeddu, C Durante, S Filetti
Journal of Molecular Endocrinology 46 (3), R73-81, 2011
1102011
Patient age–associated mortality risk is differentiated by BRAF V600E status in papillary thyroid cancer
X Shen, G Zhu, R Liu, D Viola, R Elisei, E Puxeddu, L Fugazzola, ...
Journal of Clinical Oncology 36 (5), 438, 2018
1062018
Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new …
C Carta, S Moretti, L Passeri, F Barbi, N Avenia, A Cavaliere, M Monacelli, ...
Clinical endocrinology 64 (1), 105-109, 2006
1052006
RET/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response
E Puxeddu, JA Knauf, MA Sartor, N Mitsutake, EP Smith, M Medvedovic, ...
Endocrine-Related Cancer 12 (2), 319-334, 2005
1042005
The prognostic value of tumor multifocality in clinical outcomes of papillary thyroid cancer
F Wang, X Yu, X Shen, G Zhu, Y Huang, R Liu, D Viola, R Elisei, ...
The Journal of Clinical Endocrinology & Metabolism 102 (9), 3241-3250, 2017
1032017
系统目前无法执行此操作,请稍后再试。
文章 1–20